Test Portfolio
What’s New & Exciting?
Confronting Long COVID: The Persistent Virus Hypothesis
The Immune Response to SARS-CoV-2 and Long COVID Long COVID is currently reported to affect as many as one in five...
Attomarker To Lead New Medical Intervention to Explore Monoclonal Antibody Treatment for Long COVID
EXETER, UK – 4 April 2025 – Attomarker, a leader in rapid diagnostic technology, today announced its plans for a new...
International Long COVID Awareness Day 2025
International Long COVID Awareness Day 2025 Five Years On, Long COVID Patients Are Still Being Left Behind On...
